Researchers at the Comprehensive Center for Pain & Addiction found that sleep disturbances increased vulnerability to migraine attacks, but the opposite isn't true.
Researchers have developed a new class of drugs that is able to cross the blood-brain barrier. The technology has been licensed to the startup Teleport Pharmaceuticals.